1.99
price up icon4.19%   0.08
 
loading

Immuneering Corp Stock (IMRX) Financials Data

Income Statement
Quarterly
*All numbers in millions
Period End Date 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Period Length 3 Months 3 Months 3 Months 3 Months 3 Months
Revenues
-
- - - -
Operating Expenses
5.99%
15.33
16.30 13.93 13.50 14.68
Operating Income/Loss
5.99%
-15.33
-16.30 -13.93 -13.50 -14.68
Income/Loss From Continuing Operations Before Tax
5.14%
-14.31
-15.08 -12.60 -12.19 -13.60
Income/Loss From Continuing Operations After Tax
5.14%
-14.31
-15.08 -12.60 -12.19 -13.60
Net Income/Loss
5.14%
-14.31
-15.08 -12.60 -12.19 -13.60
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
10,114%
29.37
0.2876 29.27 28.65 26.44
Diluted Average Shares
10,114%
29.37
0.2876 29.27 28.65 26.44
Basic Earnings Per Share
5.77%
-0.49
-0.52 -0.43 -0.43 -0.51
Diluted Earnings Per Share
5.77%
-0.49
-0.52 -0.43 -0.43 -0.51
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$80.78
price down icon 0.82%
$20.67
price down icon 0.53%
$353.75
price down icon 0.12%
$5.04
price down icon 2.14%
biotechnology ONC
$228.87
price up icon 0.53%
$119.94
price down icon 1.99%
Cap:     |  Volume (24h):